药学干预对接受多药治疗2型糖尿病患者临床疗效及生活质量的影响  

The impact of pharmaceutical interventions on clinical efficacy and quality of life inacceptance of multi-drug therapy patients with type 2 diabetes

作　　者：刘秀珍[1] 李琪[1] 王凤玲[1] 曹荣娟[1] 

机构地区：[1]合肥市第二人民医院,安徽230031

出　　处：《现代医药卫生》2017年第5期691-693,共3页Journal of Modern Medicine & Health

摘　　要：目的探讨药学干预对接受多药治疗2型糖尿病患者临床疗效及生活质量的影响。方法将该院2014年3月至2015年1月200例糖尿病患者分为对照组和观察组,各100例。对照组采用常规的用药指导,观察组采取糖尿病治疗药物知识教育,定期随访实施药学监护和设立咨询台提供咨询服务。结果干预9个月后,观察组患者的药物知识知晓率、规律服药率、依从性分别为89.0%、73.0%、86.0%,与对照组相比(76.0%、50.0%、51.0%),差异有统计学意义(P<0.05);观察组空腹血糖、餐后血糖、糖化血红蛋白与对照组比较,差异有统计学意义(P<0.05);观察组质量调整生命年(0.714 5年)高于对照组(0.641 5年)。结论适宜的药学干预方法可以提高接受多药治疗2型糖尿病患者的临床疗效和生活质量。Objective To explore the impact of pharmaceutical interventions on clinical efficacy and quality of life in acceptance of multi-drug therapy patients with type 2 diabetes. Methods From March 2014 to January 2015 in our hospital 200 cases of type 2 diabetes were divided into control group（n=100）and observation group（n=100）. The control group used conventional medication guide,the observation group took education of diabetes drug knowledge,set up desk provides advisory services and regular follow-up the implementation of pharmaceutical care. Results After nine months of the intervention,the observation group awareness rate of drug knowledge,the rate of regular medication,compliance were89.0%,73.0%,86.0%,respectively,compared with the control group（76.0%,50.0%,51.0%）,the difference had statistical significance（P〈0.05）;compared with the control group,the observation group fasting blood glucose,postprandial blood glucose,glycosylated hemoglobin were better,the difference had statistical significance（P〈0.05）; quality-adjusted life years of the observation group was 0.714 5 years,which was higher than that of the control group（0.641 5 years）. Conclusion Suitably accepting pharmaceutical interventions can improve the clinical efficacy and quality of life of multi-drug therapy patients with type 2 diabetes.

关 键 词：糖尿病 2型 药学服务 药剂师 生活质量 

分 类 号：R587.1[医药卫生—内分泌]